Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur

PALO ALTO, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for t

By: globenewswire_fr

Oct 16 2024
0
0 Views

ONLY AVAILABLE IN PAID PLANS

Nouveauté. A110 R Ultime : voici l'Alpine de série la plus incroyable jamais créée

Pascal Sevran (La Chance aux chansons) : Ce cadeau remarquable qu'il a fait avant de succomber à plusieurs pathologies

"Il n’y a pas de civils en Israël" : Zineb El Rhazoui visée par un signalement de Bruno Retailleau pour "apologie du terrorisme"

« L’isolement social s’intensifie » : à Boé, une réunion publique aborde le « bien vieillir »

Actualité : Bon plan – Le boîtier photo Canon EOS 90D Boîtier nu "4 étoiles" à 978,55 € (-15%)

Share this page

Guest Posts by Easy Branches

Banner advertising on easybranches network